Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-17
DOI
10.1007/s10557-021-07257-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIF‑1α in myocardial ischemia‑reperfusion injury (Review)
- (2021) Jie Zheng et al. Molecular Medicine Reports
- Roxadustat Markedly Reduces Myocardial Ischemia Reperfusion Injury in Mice
- (2020) Hiroko Deguchi et al. CIRCULATION JOURNAL
- Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors
- (2020) Milton Packer JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sodium–glucose cotransporter 2 inhibition suppresses HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice
- (2020) Ting Cai et al. Cell Death & Disease
- Mechanisms Leading to Differential Hypoxia Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics
- (2020) Milton Packer AMERICAN JOURNAL OF KIDNEY DISEASES
- A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
- (2020) Zhipeng Yan et al. Frontiers in Medicine
- Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure
- (2020) Carlos G. Santos-Gallego et al. JACC-Cardiovascular Imaging
- Things get broken: the hypoxia-inducible factor prolyl hydroxylases in ischemic heart disease
- (2019) Timm Schreiber et al. BASIC RESEARCH IN CARDIOLOGY
- Hypoxia signaling in human diseases and therapeutic targets
- (2019) Jae W. Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- DMT1 Expression and Iron Levels at the Crossroads Between Aging and Neurodegeneration
- (2019) Rosaria Ingrassia et al. Frontiers in Neuroscience
- Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease
- (2019) C. David Mazer et al. CIRCULATION
- Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
- (2019) Ryoichi Bessho et al. Scientific Reports
- Advances in Hypoxia-Inducible Factor Biology
- (2018) Hani Choudhry et al. Cell Metabolism
- ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
- (2018) Susana Cadenas FREE RADICAL BIOLOGY AND MEDICINE
- Interplay between ROS and Antioxidants during Ischemia-Reperfusion Injuries in Cardiac and Skeletal Muscle
- (2018) Tingyang Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Burden of Anemia in Chronic Kidney Disease Patients in Japan: A Literature Review
- (2018) Tadao Akizawa et al. THERAPEUTIC APHERESIS AND DIALYSIS
- High Basolateral Glucose Increases Sodium-Glucose Cotransporter 2 and Reduces Sirtuin-1 in Renal Tubules through Glucose Transporter-2 Detection
- (2018) Hiroyuki Umino et al. Scientific Reports
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition
- (2017) Gemma Olmos et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice
- (2016) Bijaya K. Nayak et al. DIABETES
- Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
- (2016) Pablo E. Pergola et al. KIDNEY INTERNATIONAL
- Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy
- (2015) Jian Guo et al. EUROPEAN HEART JOURNAL
- Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010
- (2014) Andrew E. Moran et al. CIRCULATION
- Angiogenesis and Cardiac Hypertrophy
- (2014) Toru Oka et al. CIRCULATION RESEARCH
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- (2014) Melissa E. Stauffer et al. PLoS One
- Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction
- (2014) Bingqing Huang et al. Stem Cell Research & Therapy
- A systematic analysis of global anemia burden from 1990 to 2010
- (2013) N. J. Kassebaum et al. BLOOD
- Unfavourable consequences of chronic cardiac HIF-1α stabilization
- (2012) Marion Hölscher et al. CARDIOVASCULAR RESEARCH
- Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents
- (2012) Tetsuhiro Tanaka et al. EXPERIMENTAL CELL RESEARCH
- Mechanisms of Anemia in CKD
- (2012) J. L. Babitt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Passing the baton: the HIF switch
- (2012) Mei Yee Koh et al. TRENDS IN BIOCHEMICAL SCIENCES
- Renal Anemia of Inflammation: The Name Is Self-Explanatory
- (2011) Mahmut Ilker Yilmaz et al. BLOOD PURIFICATION
- Cardiomyocyte-specific Prolyl-4-hydroxylase Domain 2 Knock Out Protects from Acute Myocardial Ischemic Injury
- (2011) Marion Hölscher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Disruption of Hypoxia-Inducible Transcription Factor-Prolyl Hydroxylase Domain-1 (PHD-1−/−) Attenuates Ex Vivo Myocardial Ischemia/Reperfusion Injury Through Hypoxia-Inducible Factor-1α Transcription Factor and Its Target Genes in Mice
- (2010) Ram Sudheer Adluri et al. ANTIOXIDANTS & REDOX SIGNALING
- Complex role of the HIF system in cardiovascular biology
- (2010) Gabor Czibik JOURNAL OF MOLECULAR MEDICINE-JMM
- HIF-1 and HIF-2 transcription factors — Similar but not identical
- (2010) Agnieszka Loboda et al. MOLECULES AND CELLS
- Conditional HIF-1α Expression Produces a Reversible Cardiomyopathy
- (2010) Raffi Bekeredjian et al. PLoS One
- Hypoxia Inducible Factor-2α Stabilization and Maxi-K + Channel β 1 -Subunit Gene Repression by Hypoxia in Cardiac Myocytes
- (2009) Lucía Bautista et al. CIRCULATION RESEARCH
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoxia-Inducible Factor-1 Is Central to Cardioprotection
- (2008) Tobias Eckle et al. CIRCULATION
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Hypoxia-Inducible Factor-Dependent Degeneration, Failure, and Malignant Transformation of the Heart in the Absence of the von Hippel-Lindau Protein
- (2008) L. Lei et al. MOLECULAR AND CELLULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search